Featured episodes

Paul Biondi discusses his role helping Flagship Pioneering’s bioplatform companies grow and thrive, as well as Pioneering Medicines, a new initiative that harnesses the power of multiple Flagship scientific platforms and technologies to create novel treatments for specialty diseases such as metabolic disorders, cardiovascular, and autoimmune diseases. Paul also talks to us about their partnership with the Cystic Fibrosis Foundation to develop breakthrough treatments for CF.

Kevin Judice, Co-Founder and CEO of Dice Therapeutics, shares his experience stepping into the CEO role for the first time at DICE and discusses the challenges of maintaining a lean startup while avoiding burnout. He also talks about how he approaches fundraising, insights for aspiring entrepreneurs, and advice he would give to his younger self.

Matt Gline is the CEO of Roivant Sciences, a company that delivers innovative medicines and technologies to patients by building Vants – nimble, entrepreneurial biotech and healthcare technology companies. Matt discusses how the current market conditions inform how Roivant operates across its portfolio, how telemedicine emerged as a silver lining from the pandemic, and his thoughts on the current labor market.

Florian Brand and Srinivas Rao are the Co-Founders and CEO & CSO, respectively, of atai Life Sciences, a biopharmaceutical company that leverages a decentralized platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients, including psychedelics and digital therapeutics. They provide an overview of the neuropsychiatry landscape and the history of psychedelics within mental health.